Details of the Drug

General Information of Drug (ID: DMLAYTP)

Drug Name
Soluble ferric pyrophosphate
Synonyms Ferric pyrophosphate; Soluble ferric pyrophosphate (anemia)
Indication
Disease Entry ICD 11 Status REF
Iron-deficiency anemia 3A00 Phase 3 [1]
Affected Organisms
Humans and other mammals
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski):
2		 Molecular Weight 745.21
Logarithm of the Partition Coefficient Not Available
Rotatable Bond Count 0
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 21
Chemical Identifiers
Formula
Fe4O21P6
IUPAC Name
iron(3+);phosphonato phosphate
Canonical SMILES
[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[Fe+3].[Fe+3].[Fe+3].[Fe+3]
InChI
InChI=1S/4Fe.3H4O7P2/c;;;;3*1-8(2,3)7-9(4,5)6/h;;;;3*(H2,1,2,3)(H2,4,5,6)/q4*+3;;;/p-12
InChIKey
CADNYOZXMIKYPR-UHFFFAOYSA-B
Cross-matching ID
PubChem CID
24877
ChEBI ID
CHEBI:132767
CAS Number
10058-44-3
UNII
QK8899250F
DrugBank ID
DB09147
TTD ID
D0Y2JM

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Iron (Fe) TTUDR0C NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Rockwell Medical Inc.
2 A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. Br J Nutr. 2004 Jan;91(1):107-12.